Canada markets close in 3 hours 39 minutes

Candel Therapeutics, Inc. (CADL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.76+0.78 (+6.51%)
As of 12:18PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 356.34M
Enterprise Value 351.71M
Trailing P/E 63.17
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)436.42
Price/Book (mrq)59.60
Enterprise Value/Revenue 821.98
Enterprise Value/EBITDA -0.01

Trading Information

Stock Price History

Beta (5Y Monthly) -0.93
52-Week Change 3639.51%
S&P500 52-Week Change 328.04%
52 Week High 314.30
52 Week Low 30.66
50-Day Moving Average 35.74
200-Day Moving Average 32.31

Share Statistics

Avg Vol (3 month) 35.59M
Avg Vol (10 day) 3869.89k
Shares Outstanding 529.74M
Implied Shares Outstanding 629.74M
Float 818.22M
% Held by Insiders 133.19%
% Held by Institutions 115.10%
Shares Short (Apr 30, 2024) 41.05M
Short Ratio (Apr 30, 2024) 40.07
Short % of Float (Apr 30, 2024) 45.37%
Short % of Shares Outstanding (Apr 30, 2024) 43.59%
Shares Short (prior month Mar 28, 2024) 4160.91k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-40.36%
Return on Equity (ttm)-125.50%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -37.43M
Net Income Avi to Common (ttm)-37.94M
Diluted EPS (ttm)-1.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.41M
Total Cash Per Share (mrq)1.21
Total Debt (mrq)22.76M
Total Debt/Equity (mrq)178.60%
Current Ratio (mrq)2.59
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-34.24M
Levered Free Cash Flow (ttm)-21.57M